The D816V-KIT Mutation Causes IL-6 Upregulation In Human Mast Cells

被引：0
|
作者：
Tobio, Araceli [1 ]
Hanjra, Pahul [1 ]
Bandara, Geethani [1 ]
Komarow, Hirsh D. [2 ]
Carter, Melody C. [1 ]
Cantave, Daly [1 ]
Metcalfe, Dean D. [1 ]
Olivera, Ana [2 ]
机构：
[1] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2017.12.932
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
927
引用
收藏
页码：AB292 / AB292
页数：1
相关论文
共 50 条
  • [1] Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production
    Tobio, Araceli
    Bandara, Geethani
    Morris, Denise A.
    Kim, Do-Kyun
    O'Connell, Michael P.
    Komarow, Hirsh D.
    Carter, Melody C.
    Smrz, Daniel
    Metcalfe, Dean D.
    Olivera, Ana
    HAEMATOLOGICA, 2020, 105 (01) : 124 - 135
  • [2] Sphingosine Kinase Inhibitors Effectively Inhibit Growth of Mast Cells with D816V-KIT Mutations
    Ageitos, Araceli Tobio
    Bandara, Geethani
    Munoz-Cano, Rosa
    Yin, Yuzhi
    Desai, Avanti
    Metcalfe, Dean
    Olivera, Ana
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [3] Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast cells With D816V-KIT
    Bandara, Geethani
    Munoz-Cano, Rosa
    Tobio, Araceli
    Yin, Yuzhi
    Komarow, Hirsh D.
    Desai, Avanti
    Metcalfe, Dean D.
    Olivera, Ana
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation
    Jin, Yanli
    Lu, Zhongzheng
    Cao, Kaiyuan
    Zhu, Yunhui
    Chen, Qi
    Zhu, Feng
    Qian, Chenchen
    Pan, Jingxuan
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (01) : 211 - 223
  • [5] CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis
    Bandara, Geethani
    Falduto, Guido H.
    Luker, Andrea
    Bai, Yun
    Pfeiffer, Annika
    Lack, Justin
    Metcalfe, Dean D.
    Olivera, Ana
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] KIT D816V mutation alters the mechanism of JAK3 phosphorylation in mastocytosis mast cells
    Chan, I.
    Kasprowicz, S.
    Tharp, M. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 88 - 88
  • [7] Mast cell sarcoma with KIT p.D816V mutation and concurrent systemic mastocytosis
    Collins, Nicholas
    Willard, Nicholas
    Pan, Zenggang
    JOURNAL OF HEMATOPATHOLOGY, 2024, 17 (04) : 281 - 287
  • [8] The upregulation of Pim kinases is essential in coordinating the survival, proliferation, and migration of KIT D816V-mutated neoplastic mast cells
    Park, Hyejoo
    Kim, Dongchan
    Koh, Youngil
    Yoon, Sung-Soo
    LEUKEMIA RESEARCH, 2019, 83
  • [9] An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
    C Teodosio
    A C García-Montero
    M Jara-Acevedo
    I Álvarez-Twose
    L Sánchez-Muñoz
    J Almeida
    J M Morgado
    A Matito
    L Escribano
    A Orfao
    Leukemia, 2012, 26 : 951 - 958
  • [10] An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
    Teodosio, C.
    Garcia-Montero, A. C.
    Jara-Acevedo, M.
    Alvarez-Twose, I.
    Sanchez-Munoz, L.
    Almeida, J.
    Morgado, J. M.
    Matito, A.
    Escribano, L.
    Orfao, A.
    LEUKEMIA, 2012, 26 (05) : 951 - 958
12345